Clinics' Pitch to Indian Émigrés: It's a Boy
By Susan Sachs,
The New York Times
| 08. 15. 2001
The pitch could not be more direct. The intended audience could not
be more specific.
"Desire a Son?" asked an advertisement in recent editions
of India Abroad, a weekly newspaper for Indian expatriates in the
United States and Canada.
"Choosing the sex of your baby: new scientific reality,"
declared another in the same publication. A third ad ran in both India
Abroad and the North American edition of The Indian Express. "Pregnant?"
it said. "Wanna know the gender of your baby right now?"
Some people would call it niche marketing — an effort by companies
to promote their products to one of the country's fastest-growing
ethnic groups.
But the products in question are not chewing gum or financial services.
They are procedures to preselect the sex of a child or, in the case
of one advertiser, to identify the sex of the fetus as early as five
weeks into a pregnancy. And the target market is immigrants from India,
where sex-determination tests were outlawed seven years ago in a still
unsuccessful effort to thwart the widespread practice of aborting
female...
Related Articles
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...
By Antonia O'Flaherty, ABC News Australia | 03.04.2026
Fertility giant Monash IVF has agreed to pay financial settlements to families involved in two major bungles that saw two women transferred the wrong embryo.
In February 2025 the company became aware that one of its Brisbane clinic's patients had...
By Dr. Marcin Śmietana, Progress Educational Trust (PET) | 03.02.2026
When a family created through surrogacy abroad returns to their home country after the birth of the child, the genetic parent(s) are usually recognised as legal parents by default. However, any parent without a genetic link to the child needs...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...